Sino Medical Sciences Technology In (688108) - Total Liabilities

Latest as of March 2026: CN¥263.39 Million CNY ≈ $38.54 Million USD

Based on the latest financial reports, Sino Medical Sciences Technology In (688108) has total liabilities worth CN¥263.39 Million CNY (≈ $38.54 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sino Medical Sciences Technology In - Total Liabilities Trend (2016–2025)

This chart illustrates how Sino Medical Sciences Technology In's total liabilities have evolved over time, based on quarterly financial data. See Sino Medical Sciences Technology In working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Sino Medical Sciences Technology In Competitors by Total Liabilities

The table below lists competitors of Sino Medical Sciences Technology In ranked by their total liabilities.

Company	Country	Total Liabilities
Biotage AB ST:BIOT	Sweden	Skr862.00 Million
Grupo Televisa S.A.B. F:TLV	Germany	€122.08 Billion
Dogan Sirketler Grubu Holding AS IS:DOHOL	Turkey	TL78.46 Billion
Celltrion Pharm Inc KQ:068760	Korea	₩319.38 Billion
United Corporations Limited TO:UNC	Canada	CA$122.62 Million
Tourmaline Bio Inc. NASDAQ:TRML	USA	$10.10 Million
Changzhou Tronly New Electronic Materials Co Ltd SHE:300429	China	CN¥1.55 Billion
China Communications Services Corporation Limited F:CMW	Germany	€87.59 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Sino Medical Sciences Technology In's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688108 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.54	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sino Medical Sciences Technology In's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sino Medical Sciences Technology In (2016–2025)

The table below shows the annual total liabilities of Sino Medical Sciences Technology In from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-931.81 Million ≈ $-136.35 Million	-331.67%
2024-12-31	CN¥402.22 Million ≈ $58.86 Million	+24.08%
2023-12-31	CN¥324.17 Million ≈ $47.44 Million	+79.96%
2022-12-31	CN¥180.13 Million ≈ $26.36 Million	+14.06%
2021-12-31	CN¥157.92 Million ≈ $23.11 Million	+13.10%
2020-12-31	CN¥139.63 Million ≈ $20.43 Million	+30.36%
2019-12-31	CN¥107.11 Million ≈ $15.67 Million	+2.18%
2018-12-31	CN¥104.83 Million ≈ $15.34 Million	+1.16%
2017-12-31	CN¥103.62 Million ≈ $15.16 Million	+32.74%
2016-12-31	CN¥78.06 Million ≈ $11.42 Million	--

About Sino Medical Sciences Technology In

SHG:688108 China Medical Devices

Market Cap

$1.23 Billion

CN¥8.43 Billion CNY

Market Cap Rank

#8169 Global

#1969 in China

Share Price

CN¥20.16

Change (1 day)

+1.05%

52-Week Range

CN¥10.69 - CN¥41.48

All Time High

CN¥42.10